Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel-Reference-Cited by-同舟云学术

Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel

Published:2023-11 Issue:5 Volume:62 Page:106960
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Senneville Eric^ORCID,Cuervo Guillermo,Gregoire Matthieu^ORCID,Hidalgo-Tenorio Carmen^ORCID,Jehl François,Miro Jose M.^ORCID,Seaton Andrew,Söderquist Bo,Soriano Alex^ORCID,Thalhammer Florian,Pea Federico^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference50 articles.

1. Origin, structure, and activity in vitro and in vivo of dalbavancin;Malabarba;J Antimicrob Chemother,2005

2. Structure-activity relationships of vancomycin-type glycopeptide antibiotics;Nagarajan;J Antibiot (Tokyo),1993

3. Annex 1. Summary of product characteristics,2015

4. Dalbavancin for the treatment of acute bacterial skin and skin structure infections HHS Public Access;Ramdeen;Expert Opin Pharmacother,2015

5. New Lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin;Zhanel;Drugs,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial peptides: Opportunities and challenges in overcoming resistance;Microbiological Research;2024-09

2. Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry;Journal of Global Antimicrobial Resistance;2024-09

3. Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections;Clinical Pharmacokinetics;2024-08-22

4. Therapeutic drug monitoring of antibiotics for methicillin-resistant Staphylococcus aureus infections: an updated narrative review for clinicians;Clinical Microbiology and Infection;2024-08

5. Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections;Antimicrobial Agents and Chemotherapy;2024-04-03